Search Results 3521-3530 of 26537 for oral

  1. Publications - John V. Murray, Jr., M.D. - Mayo Clinic

    Oral Maxillofac Surg Clin North Am. 2023 Aug; 35 (3):451-468 Epub 2023 Apr 07. View PubMed; Beegle RD, Murray JV Jr, Sandhu SJS. Normal and Variant Sinonasal ...

  2. Publications - Steven Attia, D.O. - Mayo Clinic

    Multicenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma. Ann Oncol. 2018 ...

  3. Study of INTERCEPT Blood System for Red Blood Cells in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections (RedeS) - Mayo Clinic

    ... oral contraceptives, some intrauterine devices (IUDs), sexual abstinence or vasectomized partner for the duration of study participation and an additional ...

  4. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

    ... oral calcineurin inhibitors; high potency or oral steroids). History of idiopathic pulmonary fibrosis, pneumonitis (including drug induced), organizing ...

  5. A Study to Evaluate the Safety and Tolerability of Rebiotix RBX2660 (microbiota suspension) in Subjects with Recurrent Clostridium difficile Infection - Mayo Clinic

    ... oral antibiotic therapy; or; has had at least two episodes of severe CDI resulting in hospitalization. A positive stool test for the presence of toxigenic C ...

  6. A Study of Macitentan in Pulmonary Hypertension After Left Ventricular Assist Device Implantation - Mayo Clinic

    ... oral prostanoids, or guanylate cyclase stimulators within 7 days prior to baseline RHC, or planned treatment during the study period; Treatment with inhaled ...

  7. Ryan J. Solinsky, M.D. - Doctors and Medical Staff - Mayo Clinic

    Best Oral Presentation AwardInternational Autonomic Symposium, Vancouver, BC, CAN. 2017. Post-doctoral Fellow- Best Research AwardKessler Institute for ...

  8. EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway - Mayo Clinic

    ... (oral, intravaginal, or transdermal);; Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, or implantable) ...

  9. Publications - Matthew P. Abdel, M.D. - Mayo Clinic

    Nonsteroidal Anti-Inflammatory Drugs and Oral Corticosteroids Mitigated the Risk of Arthrofibrosis After Total Knee Arthroplasty. J Arthroplasty. 2023 Jun ...

  10. Clinical trials - Oncology (Medical)

    ... orally twice daily (BID), or critozinib, 250 mg orally BID. Patients ... Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target ...